Genprex Inc (GNPX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.71M
Last updated: Nov 17, 2026 at 11:04 AM ET
Genprex Inc (GNPX) Earnings: Report Dates and Results
Genprex (GNPX) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Genprex reported EPS of -$5.30. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
GNPX has an expected report date of Mar 29, 2027.
Earnings History
Of the 27 quarters below that had an estimate, GNPX beat 10, missed 15 and matched 2. The widest gap in the table came in the quarter ended Mar 31, 2025, when EPS landed 761.54% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$5.30 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2026 |
| Jun 30, 2026 | -$9.40 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2026 |
| Mar 31, 2026 | -$14.12 | N/A | N/A | N/A | N/A | -647.3% | N/A | N/A | May 13, 2026 |
| Dec 31, 2025 | -$25.33 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2026 |
| Sep 30, 2025 | -$5.00 | -$0.65 | N/A | -669.23% | Miss | N/A | N/A | 1 up, 0 down | Nov 14, 2025 |
| Jun 30, 2025 | -$8.47 | -$0.74 | N/A | N/A | N/A | N/A | 1 | 1 up, 0 down | Aug 14, 2025 |
| Mar 31, 2025 | $2.58 | -$0.39 | N/A | +761.54% | Beat | N/A | 1 | 1 up, 0 down | Apr 7, 2025 |
| Dec 31, 2024 | -$0.42 | -$0.39 | -$0.39 - -$0.39 | -8.77% | Miss | N/A | 1 | 1 up, 0 down | Mar 31, 2025 |
| Sep 30, 2024 | -$1,353.00 | -$3,003.00 | N/A | +54.95% | Beat | N/A | 2 | 0 up, 0 down | Nov 13, 2024 |
| Jun 30, 2024 | -$3,300.00 | -$2,530.00 | N/A | -30.43% | Miss | N/A | 1 | 0 up, 0 down | Aug 9, 2024 |
| Mar 31, 2024 | -$4,059.00 | -$2,794.00 | N/A | -45.28% | Miss | N/A | 1 | 0 up, 0 down | May 15, 2024 |
| Dec 31, 2023 | -$3.96 | -$3.93 | -$5.60 - -$0.80 | -0.76% | Miss | N/A | 3 | 0 up, 0 down | Mar 29, 2024 |
| Sep 30, 2023 | -$0.13 | -$0.11 | -$0.11 - -$0.11 | -18.18% | Miss | N/A | 1 | 0 up, 0 down | Nov 14, 2023 |
| Jun 30, 2023 | -$0.15 | -$0.12 | -$0.12 - -$0.12 | -25.00% | Miss | N/A | 1 | 0 up, 0 down | Aug 21, 2023 |
| Mar 31, 2023 | -$0.19 | -$0.12 | -$0.12 - -$0.12 | -58.33% | Miss | N/A | 1 | 0 up, 0 down | May 22, 2023 |
| Dec 31, 2022 | -$6,600.01 | -$6,600.01 | N/A | 0.00% | In line | N/A | 2 | 0 up, 0 down | Mar 31, 2023 |
| Sep 30, 2022 | -$5,720.01 | -$5,280.01 | N/A | -8.33% | Miss | N/A | 1 | 0 up, 0 down | Nov 14, 2022 |
| Jun 30, 2022 | -$4,840.00 | -$5,280.01 | N/A | +8.33% | Beat | N/A | 1 | 0 up, 0 down | Aug 12, 2022 |
| Mar 31, 2022 | -$5,280.01 | -$5,280.01 | N/A | 0.00% | In line | N/A | 1 | 0 up, 0 down | May 13, 2022 |
| Dec 31, 2021 | -$0.12 | -$0.09 | -$0.11 - -$0.08 | -33.33% | Miss | N/A | 2 | 0 up, 0 down | Mar 30, 2022 |
| Sep 30, 2021 | -$3,080.00 | -$4,840.00 | N/A | +36.36% | Beat | N/A | N/A | N/A | Nov 15, 2021 |
| Jun 30, 2021 | -$3,520.00 | -$5,720.01 | N/A | +38.46% | Beat | N/A | 1 | N/A | Aug 13, 2021 |
| Mar 31, 2021 | -$6,160.01 | -$5,280.01 | N/A | -16.67% | Miss | N/A | 1 | N/A | May 17, 2021 |
| Dec 31, 2020 | -$0.14 | -$0.28 | -$0.28 - -$0.28 | +50.00% | Beat | N/A | 1 | N/A | Mar 26, 2021 |
| Sep 30, 2020 | -$3,080.00 | -$9,240.01 | N/A | +66.67% | Beat | N/A | 1 | N/A | Nov 12, 2020 |
| Jun 30, 2020 | -$5,280.01 | -$8,360.01 | N/A | +36.84% | Beat | N/A | 2 | N/A | Aug 11, 2020 |
| Mar 31, 2020 | -$8,800.01 | -$3,520.00 | N/A | -150.00% | Miss | N/A | N/A | N/A | May 14, 2020 |
| Sep 30, 2019 | -$0.15 | -$0.22 | N/A | +31.82% | Beat | N/A | N/A | N/A | Nov 14, 2019 |
| Jun 30, 2019 | -$0.24 | -$0.21 | -$0.21 - -$0.21 | -14.29% | Miss | N/A | 1 | N/A | Aug 13, 2019 |
| Mar 31, 2019 | -$6,160.01 | -$9,240.01 | -$10,109.89 - -$7,472.53 | +33.33% | Beat | N/A | 3 | N/A | Apr 1, 2019 |
| Dec 31, 2018 | -$8.00 | -$0.14 | -$0.15 - -$0.12 | N/A | N/A | N/A | 2 | N/A | Mar 29, 2019 |
| Sep 30, 2018 | -$6,600.01 | -$5,720.01 | N/A | -15.38% | Miss | N/A | N/A | N/A | Nov 14, 2018 |
| Jun 30, 2018 | -$0.31 | -$0.17 | N/A | -82.35% | Miss | N/A | N/A | N/A | Aug 14, 2018 |
| Mar 31, 2018 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2018 |
| Sep 30, 2017 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 27, 2017 |
| Jun 30, 2017 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 21, 2017 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$36.22, after -$8,712.42 the year before. It was -$6,608.49 for the year ended Dec 31, 2018, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$36.22 | N/A |
| Dec 31, 2024 | -$8,712.42 | N/A |
| Dec 31, 2023 | -$4.43 | N/A |
| Dec 31, 2022 | -$22,440.03 | N/A |
| Dec 31, 2021 | -$12,760.13 | N/A |
| Dec 31, 2020 | -$23,320.56 | N/A |
| Dec 31, 2018 | -$6,608.49 | N/A |
Frequently Asked Questions About GNPX
When is Genprex's next earnings date?
Genprex's next earnings report is expected for Mar 29, 2027.
How often does GNPX beat earnings estimates?
Genprex beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of +5.48%.
GNPX pages: Overview, Earnings, Financials, Competitors